Sixty thousand freshly isolated bone marrow derived murine neutrophils were seeded into a 96-well glass bottom plate per well in 1 × HBSS, supplemented with 0.01% BSA, w/o CaCl2, w/o MgCl2 and allowed to settle for 45 min at 37°C, following priming with 20 ng/ml TNFα (Peprotech, Rocky Hill, NJ, USA) for 20 min at 37°C. Afterwards, supernatants were removed and 5 μM of the mitochondrial ROS indicator MitoSOX (Thermo Fisher Scientific) was added followed by incubation for 30 min at 37°C. Supernatants were removed and cells were left untreated, or stimulated with 100 nM PMA, 5 μM ionomycin or 10 μM casin in 1 × HBSS supplemented with 0.01% BSA, 2 mM CaCl2, 2 mM MgCl2. The generation of mitochondrial ROS over time was detected using the Incucyte® Live-Cell Analysis System (Essen BioScience) for 1 h at 37°C every 4 min. The amount of mitochondrial ROS produced over time was analyzed using the IncuCyte Zoom elements 2000 software. To detect mitochondrial ROS formation in primary human neutrophils, 5 × 105 freshly isolated neutrophils per sample were pre-incubated with 5 μM MitoSOX for 30 min. at 37°C. Cells were left untreated or incubated with PMA (20 nM), ionomycin (10 μM) or the Cdc42 inhibitor casin (10 μM) for 1 h at 37°C. The fluorescence signal of MitoSOX was analyzed using flow cytometry.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.